Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy [PDF]
Mediators of Inflammation, 2004 PURPOSE: To investigate whether caffeic acid phenethyl ester (CAPE) and cortisone prevent proliferative vitreoretinopathy (PVR).
Yusuf Turkoz +6 more
doaj +6 more sources
Proliferative Vitreoretinopathy: A Reappraisal. [PDF]
J Clin Med, 2023 Proliferative vitreoretinopathy (PVR) remains the main cause of failure after retinal detachment (RD) surgery. Despite the development of modern technologies and sophisticated techniques for the management of RD, the growth of fibrocellular membranes within the vitreous cavity and on both sides of the retinal surface, as well as intraretinal fibrosis ...
Carpineto P, Licata AM, Ciancaglini M.
europepmc +4 more sources
The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy [PDF]
, 2013 This is an open-access article distributed under the terms of the Creative Commons Attribution License.-- et al.Proliferative vitreoretinopathy (PVR) is still the major cause of failure in retinal detachment (RD) surgery.
Salvador Pastor‐Idoate +13 more
core +6 more sources
A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques [PDF]
Journal of Ophthalmology, 2017 Rhegmatogenous retinal detachment (RRD) requires surgical intervention for its repair. There are variable techniques used for this purpose, and they are all being continuously refined.
Achia Nemet +4 more
doaj +4 more sources
Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy [PDF]
Journal of Translational MedicineBackground Platelet-derived growth factor receptor β (PDGFRβ) is the principal PDGFR isoform in retinal pigment epithelial (RPE) cells from the epiretinal membranes of patients with proliferative vitreoretinopathy (PVR).
Duo Li +8 more
doaj +2 more sources
Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice [PDF]
Nature CommunicationsProliferative vitreoretinopathy is a vision-threatening response to penetrating ocular injury, for which there is no satisfactory treatment. In this disorder, retinal pigment epithelial cells, abandon their attachment to Bruch’s membrane on the scleral ...
Min Luo +7 more
doaj +2 more sources
Proliferative vitreoretinopathy: an update on the current and emerging treatment options. [PDF]
Graefes Arch Clin Exp Ophthalmol, 2023 Proliferative vitreoretinopathy (PVR) remains the main cause of failure in retinal detachment (RD) surgery and a demanding challenge for vitreoretinal surgeons.
Ferro Desideri L +4 more
europepmc +3 more sources
p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model. [PDF]
PLoS ONE, 2023 PurposeProliferative vitreoretinopathy (PVR) is a disease process resulting from proliferation of retinal pigment epithelial (RPE) cells in the vitreous and periretinal area, leading to periretinal membrane formation and traction and eventually to ...
Qi Zhang +7 more
doaj +3 more sources
Endoscopy-assisted pars plana vitrectomy in retinal detachments associated with anterior proliferative vitreoretinopathy and epiciliary membranes [PDF]
BMC Ophthalmology, 2023 Background Proliferative vitreoretinopathy (PVR) is the leading cause of recurrent retinal detachment. Anterior PVR can contribute to recurrent retinal detachment and is often difficult to remove during conventional pars plana vitrectomy.
Radwan S. Ajlan +3 more
doaj +2 more sources
Nano-Based Drug Approaches to Proliferative Vitreoretinopathy Instead of Standard Vitreoretinal Surgery. [PDF]
Int J Mol SciProliferative vitreoretinopathy (PVR) has traditionally been managed with vitreoretinal surgery. Although there have been several recent innovations in this surgery to make the retinal approach as uninvasive as possible, the outcomes remain ...
Sorrentino FS +8 more
europepmc +3 more sources